Similarly, the HIF‐1A inhibitor (PX‐478)‐treated A549 tumor spheroids remarkably altered the mir‐210‐3p and CCL2 gene expressions in hypoxic conditions (Fig. S4C,D). The gene discussed is HIF1A; the disease is neoplasm.